Chromosome Karyotype Abnormality in Peripheral Blood Lymphocytes and Reproductive System Diseases: an Overview
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Chromosomal Abnormality in Men with Impaired Spermatogenesis
Original Article Chromosomal Abnormality in Men with Impaired Spermatogenesis Dana Mierla, M.D.1, 2*, Dumitru Jardan, M.D.1, Veronica Stoian, Ph.D.2 1. Life Memorial Hospital, Bucharest, Romania 2. Department of Genetics, Faculty of Biology, University of Bucharest, Bucharest, Romania Abstract Background: Chromosomal abnormalities and Y chromosome microdeletions are re- garded as two most frequent genetic causes associated with failure of spermatogenesis in the Caucasian population. Materials and Methods: To investigate the distribution of genetic defects in the Romanian population with azoospermia or severe oligozoospermia, karyotype anal- ysis by G-banding was carried out in 850 idiopathic infertile men and in 49 fertile men with one or more children. Screening for microdeletions in the azoospermia factor (AZF) region of Y chromosome was performed by multiplex polymerase chain reaction (PCR) on a group of 67 patients with no detectable chromosomal abnormality. The results of the two groups were compared by a two-tailed Fisher’s exact test. Results: In our study chromosomal abnormalities were observed in 12.70% and 8.16% of infertile and fertile individuals respectively. Conclusion: Our data suggests that infertile men with severe azoospermia have higher incidences of genetic defects than fertile men and also patients from any other group. Infertile men with normal sperm present a higher rate of polymorphic variants. It is important to know whether there is a genetic cause of male infertility before patients are subjected to intracytoplasmic sperm injection (ICSI) or testicular sperm extraction (TESE)/ICSI treatment. Keywords: Chromosomal Abnormality, Chromosome Microdeletion, Male Infertility, Azoospermia, Oligozoospermia Citation: Mierla D, Jardan D, Stoian V. -
A Case Report of Rare Sex Chromosomal Aneuploidy: 48,XXXY/49,XXXXY Rao Swathi S 1, Arumugam Meenakshi 2, Shetty Prashanth D 3, Shenoy Vijaya D 4
Corresponding Author: Dr. Rohit David, MBBS, Post Graduate Resident in Department of Community Medicine, Christian Medical College and Hospital, Ludhiana, Punjab. E-mail: [email protected] www.ijrhs.com Case Report ISSN (o):2321–7251 A case report of rare sex chromosomal aneuploidy: 48,XXXY/49,XXXXY Rao Swathi S 1, Arumugam Meenakshi 2, Shetty Prashanth D 3, Shenoy Vijaya D 4 1. MBBS, DNB(Paediatrics), Senior Resident, Department of Paediatrics. 2. MSc Biotechnology, Lecturer/Research Associate, Diagnostic Centre for Cytogenetics and Molecular genetics. 3. PhD, Professor/ Coordinator, Diagnostic Centre for Cytogenetics and Molecular genetics. 4. MBBS, DCH, MD(Paediatrics),Professor/Head of the Department, Department of Paediatrics. Corresponding Author: Dr Swathi S Rao, 23-13/23(1), Shivakripa, Koragappa Compound, 3 rd Cross Kapikad, Ullal, Mangalore- 575020 . Email: [email protected] Abstract: The sex chromosome aneuploidy 49,XXXXY is a rare syndrome characterized by mental retardation, severe speech impairment, multiple skeletal defects, genital abnormalities and subtle dysmorphic features. The incidence of 48,XXXY/49,XXXXY is very rare and to our knowledge only few reports of mosaicism have been reported so far but with different cell line proportions. We describe a case with 48,XXXY[16]/49,XXXXY[4] mosaicism in a four year old boy with microcephaly, short stature, expressive speech delay, and clinodactyly. Karyotyping showed mosaicism with 48XXXY[16]/49XXXXY[4] and was confirmed by FISH analysis. Key words: Short stature; Expressive speech delay; Sex chromosomal aneuploidy Key Messages: Case History: Males with subtle dysmorphism and A four year old phenotypically male, was expressive speech delay are candidates for referred for evaluation of his speech delay. -
Sex Chromosome Aneuploidies
7 Sex Chromosome Aneuploidies Eliona Demaliaj1, Albana Cerekja2 and Juan Piazze3 1Department of Obstetric-Gynecology, Faculty of Medicine, University of Tirana Hospital "Mbreteresha Geraldine", Tirane 2Gynecology and Obstetrics Ultrasound Division, ASL Roma B, Rome 3Ultrasound Division, Ospedale di Ceprano/Ospedale SS. Trinità di Sora, Frosinone 1Albania 2,3Italy 1. Introduction Sex chromosome aneuploidy is defined as a numeric abnormality of an X or Y chromosome, with addition or loss of an entire X or Y chromosome. Sex chromosome mosaicism, in which one or more populations of cells have lost or gained a sex chromosome, also is common. The most commonly occurring sex chromosome mosaic karyotypes include 45,X/46XX, 46XX/47,XXX, and 46,XY/47,XXY. Less frequent are those sex chromosome abnormalities where addition of more than one sex chromosome or a structural variant of an X or Y chromosome occur. The X chromosome is one of the two sex-determining chromosomes in many animal species, including mammals and is common in both males and females. It is a part of the XY and X0 sex-determination system. The X chromosome in humans represents about 2000 out of 20,000 - 25,0000 genes. Normal human females have 2 X-chromosomes (XX), for a total of nearly 4000 "sex-tied" genes (many of which have nothing to do with sex, other than being attached to the chromosome that is believed to cause sexual bimorphism (or polymorphism if you count more rare variations). Men have, depending on the study, 1400-1900 fewer genes, as the Y chromosome is thought to have only the remaining genes down from an estimated 1438 -~2000 (Graves 2004). -
Orphanet Report Series Rare Diseases Collection
Marche des Maladies Rares – Alliance Maladies Rares Orphanet Report Series Rare Diseases collection DecemberOctober 2013 2009 List of rare diseases and synonyms Listed in alphabetical order www.orpha.net 20102206 Rare diseases listed in alphabetical order ORPHA ORPHA ORPHA Disease name Disease name Disease name Number Number Number 289157 1-alpha-hydroxylase deficiency 309127 3-hydroxyacyl-CoA dehydrogenase 228384 5q14.3 microdeletion syndrome deficiency 293948 1p21.3 microdeletion syndrome 314655 5q31.3 microdeletion syndrome 939 3-hydroxyisobutyric aciduria 1606 1p36 deletion syndrome 228415 5q35 microduplication syndrome 2616 3M syndrome 250989 1q21.1 microdeletion syndrome 96125 6p subtelomeric deletion syndrome 2616 3-M syndrome 250994 1q21.1 microduplication syndrome 251046 6p22 microdeletion syndrome 293843 3MC syndrome 250999 1q41q42 microdeletion syndrome 96125 6p25 microdeletion syndrome 6 3-methylcrotonylglycinuria 250999 1q41-q42 microdeletion syndrome 99135 6-phosphogluconate dehydrogenase 67046 3-methylglutaconic aciduria type 1 deficiency 238769 1q44 microdeletion syndrome 111 3-methylglutaconic aciduria type 2 13 6-pyruvoyl-tetrahydropterin synthase 976 2,8 dihydroxyadenine urolithiasis deficiency 67047 3-methylglutaconic aciduria type 3 869 2A syndrome 75857 6q terminal deletion 67048 3-methylglutaconic aciduria type 4 79154 2-aminoadipic 2-oxoadipic aciduria 171829 6q16 deletion syndrome 66634 3-methylglutaconic aciduria type 5 19 2-hydroxyglutaric acidemia 251056 6q25 microdeletion syndrome 352328 3-methylglutaconic -
Abstracts from the 51St European Society of Human Genetics Conference: Electronic Posters
European Journal of Human Genetics (2019) 27:870–1041 https://doi.org/10.1038/s41431-019-0408-3 MEETING ABSTRACTS Abstracts from the 51st European Society of Human Genetics Conference: Electronic Posters © European Society of Human Genetics 2019 June 16–19, 2018, Fiera Milano Congressi, Milan Italy Sponsorship: Publication of this supplement was sponsored by the European Society of Human Genetics. All content was reviewed and approved by the ESHG Scientific Programme Committee, which held full responsibility for the abstract selections. Disclosure Information: In order to help readers form their own judgments of potential bias in published abstracts, authors are asked to declare any competing financial interests. Contributions of up to EUR 10 000.- (Ten thousand Euros, or equivalent value in kind) per year per company are considered "Modest". Contributions above EUR 10 000.- per year are considered "Significant". 1234567890();,: 1234567890();,: E-P01 Reproductive Genetics/Prenatal Genetics then compared this data to de novo cases where research based PO studies were completed (N=57) in NY. E-P01.01 Results: MFSIQ (66.4) for familial deletions was Parent of origin in familial 22q11.2 deletions impacts full statistically lower (p = .01) than for de novo deletions scale intelligence quotient scores (N=399, MFSIQ=76.2). MFSIQ for children with mater- nally inherited deletions (63.7) was statistically lower D. E. McGinn1,2, M. Unolt3,4, T. B. Crowley1, B. S. Emanuel1,5, (p = .03) than for paternally inherited deletions (72.0). As E. H. Zackai1,5, E. Moss1, B. Morrow6, B. Nowakowska7,J. compared with the NY cohort where the MFSIQ for Vermeesch8, A. -
Klinefelter Syndrome—A Clinical Update
SPECIAL FEATURE Clinical Review Klinefelter Syndrome—A Clinical Update Kristian A. Groth, Anne Skakkebæk, Christian Høst, Claus Højbjerg Gravholt, and Anders Bojesen Departments of Molecular Medicine (K.A.G., C.H.G.) and Endocrinology and Internal Medicine (A.S., C.H., C.H.G.), Aarhus University Hospital, DK-8000 Aarhus C, Denmark; and Department of Clinical Genetics (A.B.), Vejle Hospital, Sygehus Lillebaelt, 7100 Vejle, Denmark Context: Recently, new clinically important information regarding Klinefelter syndrome (KS) has been published. We review aspects of epidemiology, endocrinology, metabolism, body composi- tion, and neuropsychology with reference to recent genetic discoveries. Evidence Acquisition: PubMed was searched for “Klinefelter,” “Klinefelter’s,” and “XXY” in titles and abstracts. Relevant papers were obtained and reviewed, as well as other articles selected by the authors. Evidence Synthesis: KS is the most common sex chromosome disorder in males, affecting one in 660 men. The genetic background is the extra X-chromosome, which may be inherited from either parent. Most genes from the extra X undergo inactivation, but some escape and serve as the putative genetic cause of the syndrome. KS is severely underdiagnosed or is diagnosed late in life, roughly 25% are diagnosed, and the mean age of diagnosis is in the mid-30s. KS is associated with an increased morbidity resulting in loss of approximately 2 yr in life span with an increased mor- tality from many different diseases. The key findings in KS are small testes, hypergonadotropic hypogonadism, and cognitive impairment. The hypogonadism may lead to changes in body com- position and a risk of developing metabolic syndrome and type 2 diabetes. -
Genetics of Azoospermia
International Journal of Molecular Sciences Review Genetics of Azoospermia Francesca Cioppi , Viktoria Rosta and Csilla Krausz * Department of Biochemical, Experimental and Clinical Sciences “Mario Serio”, University of Florence, 50139 Florence, Italy; francesca.cioppi@unifi.it (F.C.); viktoria.rosta@unifi.it (V.R.) * Correspondence: csilla.krausz@unifi.it Abstract: Azoospermia affects 1% of men, and it can be due to: (i) hypothalamic-pituitary dysfunction, (ii) primary quantitative spermatogenic disturbances, (iii) urogenital duct obstruction. Known genetic factors contribute to all these categories, and genetic testing is part of the routine diagnostic workup of azoospermic men. The diagnostic yield of genetic tests in azoospermia is different in the different etiological categories, with the highest in Congenital Bilateral Absence of Vas Deferens (90%) and the lowest in Non-Obstructive Azoospermia (NOA) due to primary testicular failure (~30%). Whole- Exome Sequencing allowed the discovery of an increasing number of monogenic defects of NOA with a current list of 38 candidate genes. These genes are of potential clinical relevance for future gene panel-based screening. We classified these genes according to the associated-testicular histology underlying the NOA phenotype. The validation and the discovery of novel NOA genes will radically improve patient management. Interestingly, approximately 37% of candidate genes are shared in human male and female gonadal failure, implying that genetic counselling should be extended also to female family members of NOA patients. Keywords: azoospermia; infertility; genetics; exome; NGS; NOA; Klinefelter syndrome; Y chromosome microdeletions; CBAVD; congenital hypogonadotropic hypogonadism Citation: Cioppi, F.; Rosta, V.; Krausz, C. Genetics of Azoospermia. 1. Introduction Int. J. Mol. Sci. -
Possible Misdiagnosis of 46,XX Testicular Disorders of Sex
Int. J. Med. Sci. 2020, Vol. 17 1136 Ivyspring International Publisher International Journal of Medical Sciences 2020; 17(9): 1136-1141. doi: 10.7150/ijms.46058 Research Paper Possible misdiagnosis of 46,XX testicular disorders of sex development in infertile males Tong Chen1,2†, Linlin Tian1,3†, Xianlong Wang1, Demin Fan4, Gang Ma1, Rong Tang1, Xujun Xuan1,5 1. Center for Reproductive Medicine, Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics; The Key Laboratory for Reproductive Endocrinology of Ministry of Education, Jinan, Shandong 250021, P.R. China 2. Department of Pediatric Surgery, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, 200062, P.R. China 3. Department of microbiology, Faculty of Basic Medical Sciences, Guilin Medical University, Guilin, Guangxi 541004, P.R. China 4. Department of Urology, Shandong Provincial Qianfoshan Hospital, Jinan, Shandong 250002, P.R. China 5. Department of Andrology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, P.R. China. †Tong Chen and Linlin Tian contributed equally to this study. Corresponding author: Xujun Xuan, Department of Andrology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, P.R. China. E-mail: [email protected] © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2020.03.16; Accepted: 2020.04.23; Published: 2020.05.11 Abstract Objectives: The 46,XX disorders of sex development (DSD) is a rare genetic cause of male infertility and possible misdiagnosis of this condition has never been reported. -
XX Male: a Report of Two Unrelated Cases and Review of Literature
XX Male: A report of two unrelated cases and review of literature. Sawsan J. Abulhasan, Laila A. Bastaki, Fawziah M. Mohammed, Kamal K.Naguib, Sayed AR. Gouda, Jaber Al-Tahoo, Sadika A. Al-Awadi. From the Kuwait Medical Genetics Center, Kuwait. Abstract: Two unrelated phenotypically males with 46,XX karyotype are presented. The first patient is 5.5 year old who presented with congenital undescended testis while the other patient is 35 year old who has infertility since 6 years. Hormonal profile of the second patient is consistent with hypergonadotrophic hypogonadism with low testosterone level. The first patient's profile revealed a picture consistent with 21-hydroxylase deficiency. FISH technique using (Quint-Essential-Y-specific DNA probe) specific for Yp11.2 region was applied on metaphase spreads revealed the presence of Yp11.2 sequence on the short arm of the X chromosome in the second patient while it was absent in the first patient. DNA analysis of both patients using SRY gene amplification revealed the existence of SRY gene in the second patient and absence of the gene in the first patient. The possible underlying mechanisms for sex reverse in both cases are discussed. Introduction: hybridization, detection and amplification were done according to the manufactures instruction XX males are characterized by the presence of with slight modifications. Slides were counter testes and external male genitalia despite a stained with propidium iodide (0.6 µg/mL) in 46,XX karyotype(1) In about 80% of these antiffade solution (0.3 µg/mL). Hybridized cells individuals the male differentiation of the gonads were examined under a Zeiss axiophote can be ascribed to the presence of Y specific microscope equipped with a fluorescence filter DNA including the SRY gene which encodes the sets. -
Endodontic Management of a Hypertaurodontic Tooth Associated
Case Report Endodontic management of a hypertaurodontic tooth associated with 48, XXYY syndrome: A review and case report Sridevi Krishnamoorthy#, Velayutham Gopikrishna* Department of Conservative Dentistry and Endodontics, Thai Moogambigai Dental College, Dr. MGR Educational and Research Institute University, Chennai, Tamil Nadu, India Abstract Taurodontism is a developmental anomaly of a tooth characterized by large pulp chamber and short roots. Patients with multiple taurodontic teeth are associated with the probability of a systemic syndrome or chromosomal anomaly. This is the first reported incidence of the endodontic management of a hyper taurodontic mandibular second molar in a patient diagnosed with 48, XXYY syndrome. Keywords: XXY/Klinefelter syndrome; 48, XXYY syndrome; hypertaurodontism INTRODUCTION Multiple taurodontic teeth may occur as one of the dental manifestations of XXYY syndrome. The presence of XXYY syndrome also known as 48, XXYY syndrome or “double taurodontic teeth can facilitate early recognition of this male syndrome” is a rare sex chromosome aneuploidy disorder. This could provide means for an effective systemic condition characterized by presence of two extra X and Y rehabilitation.[4] This is the first reported incidence of the chromosomes with an incidence of 1:18,000-1:40,000 male endodontic management of a hypertaurodontic mandibular births.[1-3] This syndrome is clinically manifested later in life molar tooth in a patient diagnosed with 48, XXYY syndrome. with developmental delays, learning disabilities, behavioral problems, and delayed or incomplete puberty. Many cases go CASE REPORT undiagnosed as most of the above mentioned abnormalities [4,5] do not develop until early puberty. A 19-year-old male reported to the postgraduate department of endodontics of our dental school, for The term taurodontism was coined by Sir Arthur Kein management of multiple carious teeth. -
1. Growth and Endocrine Data in Children After Brain Tumor and Irradiation
ENDOCRINE REGULATIONS, Vol. 33, 37 – 53, 2000 37 1. GROWTH AND ENDOCRINE DATA IN CHILDREN AFTER BRAIN TUMOR AND IRRADIATION G. HEUSSLER, K. UTERMANN, H. FRISH, 1E. SCHULLER, 1I. SLAUVE Endocrinology and 1Oncology, Pediatric Department, University of Vienna, Austria Due to advances in therapeutic regimes of malig- cases the thyroid function noramlizes. These stud- nant brain tumors in childhood the survival rates have ies retrospectively analyzed the data of patients af- significantly improve over the last decades. Besides ter various treatment protocols with a wide range neurological problems, long-term survivors of child of irradiation doses and time after the end of treat- brain tumors are at high risk of developing irradia- ment. tion induced hypothalamic-pituitary dysfunction, pri- We recently started an endocrine and auxiologi- mary hypothyroidism and severe growth retardation cal analysis of patients treated for brain tumors in due to diminished growth of the spine after cran- our department and so far treated 18 of such patients. iospinal irradiation and additional hormonal defi- The aim of this study was to define the frequency ciency. In several patients the first clinical sign of and time course of growth- and endocrine deficien- endocrine disturbance is the precocious or early pu- cies in this homogenous groups of patients as de- berty. Thus, the growth velocity may be normal even fined by the rather high irradiation dose combined in spite of the presence of growth hormone deficien- with chemotherapy. On the basis of these data we cy which results in late diagnosis and treatment and further aim to define a prospective protocol for aux- further results in severely affected body height in iological and endocrine investigations. -
Back Matter 611-642.Pdf
Index A Acrodysostosis, 527, 538 Aarskog syndrome, 527, 537 Acrofacial dysostosis 1, 580–581 differentiated from Opitz G/BBB Acrofacial dysplasia, 563 syndrome, 458 Acro-fronto-facio-nasal dysostosis Aase-Smith syndrome, 527 syndrome, 527, 538–539 Aase syndrome, 527, 537 Acromegaloid facial appearance Abducens nerve. See Cranial nerve VI syndrome, 527, 539 Abduction, Möbius sequence-related Acromegaloid phenotype-cutis verticis impairment of, 197, 198 gyrata-cornea leukoma, 527, 539 Abetalipoproteinemia, 527, 537 Acromesomelic dysplasia, Maroteaux- Ablepharon-macrostomia syndrome, Martinelli-Campailla type, 527, 527, 538 539 Abortion, spontaneous, chromosomal Acromicric dysplasia, 527, 539 abnormalities associated with, 83 Acro-osteolysis syndrome, 565 Abruzzo-Erickson syndrome, 527, 538 Acro-reno-ocular syndrome, 527, Acanthosis, 607 539 Acanthosis nigricans, Crouzon Acyclovir, 504, 505, 518 syndrome-related, 169 Adam complex, 207–209 Physician-parent interactions, Adams-Oliver syndrome, 527, 540 69–70 Adduction, Möbius sequence-related Acetyl-coenzyme A deficiency, 364 impairment of, 197, 198 N-Acetylcystine, 321 Adenoma sebaceum, tuberous sclerosis N-Acetyl galactosamine-4-sulfatase complex-related, 304, 308–309 deficiency, 366 Adrenocorticotropic hormone, 433 N-Acetyl galactosamine-6-sulfatase Aging, premature. See also Progeria deficiency, 357, 365 ataxia-telangiectasia-related, 320 a-N-Acetyl glucosaminidase acetyl Aglossia-adactyly syndrome, 584–585 transferase deficiency, 357 Agnathia-holoprosencephaly, 54 a-N-Acetyl glucosaminidase